Home  |  Contact

Cellosaurus HepG2S3 (CVCL_4W44)

[Text version]

Cell line name HepG2S3
Accession CVCL_4W44
Resource Identification Initiative To cite this cell line use: HepG2S3 (RRID:CVCL_4W44)
Comments Selected for resistance to: ChEBI; CHEBI:50924; Sorafenib (Nexavar).
Sequence variations NRAS p.Gln61Leu (c.182A>T) (from parent cell line).
TERT c.228C>T (-124C>T); in promoter (from parent cell line).
Disease Hepatoblastoma (NCIt: C3728)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0027 (Hep-G2)
Sex of cell Male
Age at sampling 15Y
Category Cancer cell line
Publications

PubMed=23111106; DOI=10.1016/j.canlet.2012.10.021
van Malenstein H., Dekervel J., Verslype C., Van Cutsem E., Windmolders P., Nevens F., van Pelt J.
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth.
Cancer Lett. 329:74-83(2013)

Cross-references
Other Wikidata; Q54882863
Entry history
Entry creation14-Dec-2015
Last entry updated05-Jul-2019
Version number5